Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1

被引:20
|
作者
Ishida, M
Tanaka, S
Ohki, M
Ohta, T
机构
[1] Natl Canc Ctr, Res Inst, Ctr Med Genom, Chuo Ku, Tokyo 1040045, Japan
[2] Hokkaido Univ, Sch Med, Lab Mol & Cellular Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan
关键词
D O I
10.1111/j.1356-9597.2004.00737.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The t(X;18)(p11.2;q11.2) translocation found in synovial sarcomas results in the fusion of the SYT gene on chromosome 18 to the SSX gene on chromosome X. Although the SYT-SSX fusion proteins may trigger synovial sarcoma development, the biological functions of SYT, SSX and SYT-SSX genes are unclear. Transfections of Gal4 DNA binding domain fusion protein constructs demonstrate that SYT protein acts as a transcriptional co-activator at the C-terminal domain and that the activity is repressed through the N-terminus. The N-terminal 70 amino acids of SYT bind not only to BRM, but also to Brg1, both of which are subunits of SWI/SNF chromatin remodelling complexes. Here, we have investigated the functions of BRM and Brg1 on the repression of SYT activity. The negative regulation of SYT transcriptional co-activator activity is dependent on the ATP-hydrolysis of BRM and Brg1 in the protein complexes. This indicates that the SWI/SNF protein complexes regulate SYT activity using the chromatin remodelling activity.
引用
收藏
页码:419 / 428
页数:10
相关论文
共 50 条
  • [1] Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes
    Kadam, S
    Emerson, BM
    MOLECULAR CELL, 2003, 11 (02) : 377 - 389
  • [2] BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists
    Wang, S
    Zhang, BH
    Faller, DV
    EMBO JOURNAL, 2004, 23 (11): : 2293 - 2303
  • [3] Antagonistic Roles for BRM and BRG1 SWI/SNF Complexes in Differentiation
    Flowers, Stephen
    Nagl, Norman G., Jr.
    Beck, George R., Jr.
    Moran, Elizabeth
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (15) : 10067 - 10075
  • [4] The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 Ligase PIAS1
    Li, Shujing
    Yang, Chunhua
    Hong, Yongde
    Bi, Hailian
    Zhao, Feng
    Liu, Ying
    Ao, Xiang
    Pang, Pengsha
    Xing, Xinrong
    Chang, Alan K.
    Xiao, Liyun
    Zhang, Yuanyuan
    Wu, Huijian
    BIOLOGY OF THE CELL, 2012, 104 (05) : 287 - 296
  • [5] Preclinical efficacy of BRG1/BRM ATPase inhibitor in B lymphoblastic leukemia
    Garcia, Isela
    Sivandzade, Farzane
    Wither, Matthew
    Rau, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Co-activator Activator (CoAA) Prevents the Transcriptional Activity of Runt Domain Transcription Factors
    Li, Xiaodong
    Hoeppner, Luke H.
    Jensen, Eric D.
    Gopalakrishnan, Rajaram
    Westendorf, Jennifer J.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (02) : 378 - 387
  • [7] Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits
    Raab, Jesse R.
    Runge, John S.
    Spear, Camarie C.
    Magnuson, Terry
    EPIGENETICS & CHROMATIN, 2017, 10
  • [8] The transcriptional co-activator PCAF regulates cdk2 activity
    Mateo, Francesca
    Vidal-Laliena, Miriam
    Canela, Nuria
    Zecchin, Annalisa
    Martinez-Balbas, Marian
    Agell, Neus
    Giacca, Mauro
    Jesus Pujol, Maria
    Bachs, Oriol
    NUCLEIC ACIDS RESEARCH, 2009, 37 (21) : 7072 - 7084
  • [9] BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL
    Garland, Gavin D.
    Ducray, Stephen P.
    Jahangiri, Leila
    Pucci, Perla
    Amos Burke, G. A.
    Monahan, Jack
    Lai, Raymond
    Merkel, Olaf
    Schiefer, Ana-Iris
    Kenner, Lukas
    Bannister, Andrew J.
    Turner, Suzanne D.
    CANCERS, 2022, 14 (01)
  • [10] Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits
    Jesse R. Raab
    John S. Runge
    Camarie C. Spear
    Terry Magnuson
    Epigenetics & Chromatin, 10